open/close global search bar

22 July 2018 by Sanjiv Shah

Conference talk

Neladenoson bialanate in patients with chronic HFpEF (PANACHE)

About the author

profile picture of Sanjiv Shah

Sanjiv Shah

United States

Comments (0)

Related Content

María Isabel Marquina Rodríguez: Best abstract - Survivin inhibition as a potential target for pulmonary arterial hypertension thumbnail image

Conference talk

16 March 2020

{{GlobalController.truncateTitle("María Isabel Marquina Rodríguez: Best abstract - Survivin inhibition as a potential target for pulmonary arterial hypertension ", 65)}}
Ralph Schermuly: Cyclin-dependent kinase inhibition as new treatment concept in PH thumbnail image

Conference talk

16 March 2020

{{GlobalController.truncateTitle("Ralph Schermuly: Cyclin-dependent kinase inhibition as new treatment concept in PH", 65)}}
Elena Goncharova: TSC2: New molecular target for therapeutic intervention in PAH thumbnail image

Conference talk

16 March 2020

{{GlobalController.truncateTitle("Elena Goncharova: TSC2: New molecular target for therapeutic intervention in PAH", 65)}}
Maria Trojanowska: GATA6 deficiency as a molecular target for PAH thumbnail image

Conference talk

16 March 2020

{{GlobalController.truncateTitle("Maria Trojanowska: GATA6 deficiency as a molecular target for PAH", 65)}}
Soni Savai-Pullamsetti: FoxO re-activation and and beyond – the epigenetic treatment arsenal thumbnail image

Conference talk

16 March 2020

{{GlobalController.truncateTitle("Soni Savai-Pullamsetti: FoxO re-activation and and beyond – the epigenetic treatment arsenal", 65)}}

Add to reading list

Please enter a list name.

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg